Carsatrin

This classification denotes a cardiotonic agent with the molecular formula C25H26F2N6OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 2E3S34L69I chemically known as 1-piperazineethanol, 4-(bis(4-fluorophenyl)methyl)-.alpha.-((9h-purin-6-ylthio)methyl)-, (+/-)- but generally known as carsatrin, which bears US NIH Compound Identifier 72049. European Medicines Agency schedules Carsatrin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06147MIG. The term CARSATRIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, no3, 1993, list 33). Most nations schedule carsatrin under HS 29335995 and SITC 51576. As of Q4 2014, CARSATRIN remains the US FDA Preferred Term for this commodity. Carsatrin bears US NLM identifiers UMLS ID C0211730 and NCI Concept Code C79875. SMILES: C1CN(CCN1CC(CSC2=NC=NC3=C2NC=N3)O)C(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F.